These findings are consistent with our results, wherein LSE supplementation ameliorated hepatic steatosis and fibrosis in HFD/STZ-induced mice (Figure 3), alongside modulation of insulin signaling and a reduction in pro-inflammatory markers (Figure 6D and Figure 7D). This evidence concerns the gene INS and fatty liver disease.